Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen H Culp

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Urology|September 21, 2010
Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessmentE Jason Abel, Stephen H Culp, Surena F Matin, et al.
European Urology|May 31, 2011
Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinomaBrian F Chapin, Scott E Delacroix, Stephen H Culp, et al.
Journal of the American Chemical Society|May 20, 2016
Gold Nanoparticle Coated Carbon Nanotube Ring with Enhanced Raman Scattering and Photothermal Conversion Property for Theranostic ApplicationsJibin Song, Feng Wang, Xiangyu Yang, et al.
European Urology|January 1, 2013
Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinomaVitaly Margulis, Shahrokh F Shariat, Yury Rapoport, et al.
Cancer|June 10, 2020
Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapyAndrew G McIntosh, Eric C Umbreit, Levi C Holland, et al.
The Prostate|September 16, 2004
Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumorsStephen R Plymate, Marie K Tennant, Stephen H Culp, et al.
The Journal of Urology|August 6, 2013
Refining patient selection for neoadjuvant chemotherapy before radical cystectomyStephen H Culp, Rian J Dickstein, H Barton Grossman, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Urology|September 21, 2010
Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessmentE Jason Abel, Stephen H Culp, Surena F Matin, et al.
European Urology|May 31, 2011
Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinomaBrian F Chapin, Scott E Delacroix, Stephen H Culp, et al.
Journal of the American Chemical Society|May 20, 2016
Gold Nanoparticle Coated Carbon Nanotube Ring with Enhanced Raman Scattering and Photothermal Conversion Property for Theranostic ApplicationsJibin Song, Feng Wang, Xiangyu Yang, et al.
European Urology|January 1, 2013
Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinomaVitaly Margulis, Shahrokh F Shariat, Yury Rapoport, et al.
Cancer|June 10, 2020
Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapyAndrew G McIntosh, Eric C Umbreit, Levi C Holland, et al.
The Prostate|September 16, 2004
Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumorsStephen R Plymate, Marie K Tennant, Stephen H Culp, et al.
The Journal of Urology|August 6, 2013
Refining patient selection for neoadjuvant chemotherapy before radical cystectomyStephen H Culp, Rian J Dickstein, H Barton Grossman, et al.
Pageof 3